MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+gastric or gastroesophageal junction adenocarcinoma—Trial in progress Meeting Abstract
| Authors: | Catenacci, D. V. T.; Strickler, J. H.; Nakamura, Y.; Shitara, K.; Janjigian, Y. Y.; Barzi, A.; Bekaii-Saab, T. S.; Lenz, H. J.; Chung, H. C. C.; Tabernero, J.; Yoshino, T.; Siena, S.; Mayor, J. G.; Palanca-Wessels, M. C.; Xie, D.; Marshall, J. |
| Abstract Title: | MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+gastric or gastroesophageal junction adenocarcinoma—Trial in progress |
| Meeting Title: | 2022 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2022 Jan 20-22 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-01 |
| Language: | English |
| ACCESSION: | WOS:000770995900359 |
| DOI: | 10.1200/JCO.2022.40.4_suppl.TPS371 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS371 -- Meeting was conducted online as well as in person -- Source: Wos |
